| 臺大學術典藏 |
2020-03-05T06:05:32Z |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. |
| 國家衛生研究院 |
2024-08-12 |
Real-world insights from comprehensive genomic profiling across multiple cancer types
|
Hung, LJ;Huang, CY;Chen, JS;Huang, WK;Hsu, CC;Fang, YF;Wang, CL;Liu, PC;Yeh, KY;Chang, PH;Chang, JWC;Lin, YC;Huang, SF;Chou, WC |
| 臺大學術典藏 |
2021-08-15T00:08:17Z |
Real-world insights into patients with advanced NSCLC and MET alterations
|
Bittoni, Marisa; CHIH-HSIN YANG; JIN-YUAN SHIH; Peled, Nir; Smit, Egbert F.; Camidge, D. Ross; Arasada, Rajeswara Rao; Oksen, Dina; Boutmy, Emmanuelle; Stroh, Christopher; Johne, Andreas; Carbone, David P.; Paik, Paul K. |
| 臺大學術典藏 |
2021-11-03T02:33:00Z |
Real-world insights into patients with advanced NSCLC and MET alterations
|
Bittoni M.; Yang J.C.-H.; JIN-YUAN SHIH; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K. |
| 臺大學術典藏 |
2022-08-10T02:37:40Z |
Real-world insights into patients with advanced NSCLC and MET alterations
|
Bittoni M.; CHIH-HSIN YANG; Shih J.-Y.; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K. |
| 臺大學術典藏 |
2022-02-22T05:34:08Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 國立交通大學 |
2019-04-03T06:37:18Z |
Real-World Neuroimaging Technologies
|
McDowell, Kaleb; Lin, Chin-Teng; Oie, Kelvin S.; Jung, Tzyy-Ping; Gordon, Stephen; Whitaker, Keith W.; Li, Shih-Yu; Lu, Shao-Wei; Hairston, W. David |
| 臺大學術典藏 |
2020-05-26T09:26:29Z |
Real-World or Controlled Clinical Trial Data in Real-World Practice
|
Chih-Hsin Yang;Wu T.-H; Wu T.-H; CHIH-HSIN YANG |
| 國立成功大學 |
2024-05-16 |
Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer
|
Chang;Gee-Chen;Shih;Jin-Yuan;Yu;Chong-Jen;Chao;Heng-Sheng;Yang;Cheng-Ta;Lin;Chien-Chung;Hung;Jen-Yu;Hsiao;Sheng-Yen;Wang;Chin-Chou;Chian;Chih-Feng;Hsia;Te-Chun;Chen;Yuh-Min |
